Annual Working Capital
$76.56 M
+$41.90 M+120.86%
December 31, 2023
Summary
- As of February 8, 2025, JSPR annual working capital is $76.56 million, with the most recent change of +$41.90 million (+120.86%) on December 31, 2023.
- During the last 3 years, JSPR annual working capital has risen by +$59.89 million (+359.21%).
- JSPR annual working capital is now -4.07% below its all-time high of $79.81 million, reached on December 31, 2021.
Performance
JSPR Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$82.35 M
-$16.27 M-16.49%
September 30, 2024
Summary
- As of February 8, 2025, JSPR quarterly working capital is $82.35 million, with the most recent change of -$16.27 million (-16.49%) on September 30, 2024.
- Over the past year, JSPR quarterly working capital has dropped by -$10.96 million (-11.75%).
- JSPR quarterly working capital is now -33.92% below its all-time high of $124.62 million, reached on March 31, 2023.
Performance
JSPR Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
JSPR Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +120.9% | -11.8% |
| 3 y3 years | +359.2% | -11.8% |
| 5 y5 years | +359.2% | -11.8% |
JSPR Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.1% | +120.9% | -33.9% | +137.5% |
| 5 y | 5-year | -4.1% | +359.2% | -33.9% | +393.9% |
| alltime | all time | -4.1% | +359.2% | -33.9% | +393.9% |
Jasper Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $82.35 M(-16.5%) |
| Jun 2024 | - | $98.61 M(-11.5%) |
| Mar 2024 | - | $111.39 M(+45.5%) |
| Dec 2023 | $76.56 M(+120.9%) | $76.56 M(-17.9%) |
| Sep 2023 | - | $93.31 M(-14.9%) |
| Jun 2023 | - | $109.59 M(-12.1%) |
| Mar 2023 | - | $124.62 M(+259.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $34.67 M(-56.6%) | $34.67 M(-22.9%) |
| Sep 2022 | - | $44.99 M(-20.6%) |
| Jun 2022 | - | $56.66 M(-16.5%) |
| Mar 2022 | - | $67.83 M(-15.0%) |
| Dec 2021 | $79.81 M(+378.7%) | $79.81 M(-14.4%) |
| Sep 2021 | - | $93.25 M(+459.3%) |
| Dec 2020 | $16.67 M | $16.67 M |
FAQ
- What is Jasper Therapeutics annual working capital?
- What is the all time high annual working capital for Jasper Therapeutics?
- What is Jasper Therapeutics annual working capital year-on-year change?
- What is Jasper Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Jasper Therapeutics?
- What is Jasper Therapeutics quarterly working capital year-on-year change?
What is Jasper Therapeutics annual working capital?
The current annual working capital of JSPR is $76.56 M
What is the all time high annual working capital for Jasper Therapeutics?
Jasper Therapeutics all-time high annual working capital is $79.81 M
What is Jasper Therapeutics annual working capital year-on-year change?
Over the past year, JSPR annual working capital has changed by +$41.90 M (+120.86%)
What is Jasper Therapeutics quarterly working capital?
The current quarterly working capital of JSPR is $82.35 M
What is the all time high quarterly working capital for Jasper Therapeutics?
Jasper Therapeutics all-time high quarterly working capital is $124.62 M
What is Jasper Therapeutics quarterly working capital year-on-year change?
Over the past year, JSPR quarterly working capital has changed by -$10.96 M (-11.75%)